Ophthalmology

Ophthalmology - most related articles:

- Age related macular degeneration AMD affects 1 million Canadians - 3.4
- Gene therapy may improve vision in congenital blindness LCA - 3
- Genes involved in inflammation may hold clue to age-related macular degeneration - 2.8
- Smoking increases AMD risk even after age 80 - 2.7
- Stem cells may recover lost vision in cloudy cornea - 2.6
- Eyes could serve as early warning of diabetes - 2.5
- Eye test for early detection of Alzheimer's and Down syndrome - 2.4

Ophthalmology articles

AMD prevalence lowered in US
An estimated 6.5 percent of Americans age 40 and older have the eye disease age related macular degeneration, a lower rate than was reported 15 years ago, according to a report in the Archives of Ophthalmology.

Age related macular degeneration AMD affects 1 million Canadians
Dr. Jean-Daniel Arbour and Dr. Pierre Labelle of the Université de Montréal Department of Ophthalmology, along with two colleagues from France, have authored a new book to prevent vision loss, AMD: Age-Related Macular Degeneration (Annika Parance Publisher; 121 pages).

Eye test for early detection of Alzheimer's and Down syndrome
Researchers are going to develop an innovative eye test for early detection of Alzheimer's disease and Down syndrome. As they discovered the protein that forms plaques in the brain in Alzheimer's disease also accumulates in the eyes of people with Down syndrome.

Smoking increases AMD risk even after age 80
Smoking, even after age 80, continues to increase one's risk for age-related macular degeneration (AMD), the leading cause of blindness in Americans over 65.

Myopia or nearsightedness more common in Americans
Myopia (nearsightedness) may have been more common in Americans from 1999 to 2004 than it was 30 years ago, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Stem cells may recover lost vision in cloudy cornea
New research from the University of Cincinnati (UC) may help in the recovery of lost vision for patients with corneal scarring.

Cataract surgery does not progress AMD
Age related macular degeneration does not appear to progress at a higher rate among individuals who have had surgery to treat cataract, revealed by researchers.

Besivance eye drop approved to treat bacterial conjunctivitis
The U.S. Food and Drug Administration approved Besivance (besifloxacin ophthalmic suspension 0.6 percent) for the treatment of bacterial conjunctivitis (non-viral), a contagious condition marked by irritation of the eyes and a discharge from the mucous membranes.

Eating fish, nuts, olive oil reduce AMD risk
Regularly eating fish, nuts, olive oil and other foods containing omega-three fatty acids and avoiding trans fats appears to be associated with a lower risk for the eye disease age-related macular degeneration, according to two reports in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

UCL–Pfizer to develop stem cell sight therapies
UCL has entered into a collaboration with the biopharmaceutical group Pfizer, negotiated by UCL Business, to advance development of stem cell-based therapies for age-related macular degeneration (AMD).

Refractive errors affect vision more in Americans
About half of U.S. adults age 20 and older have refractive errors, or eye problems that result in less than 20/20 vision, according to a report in the August issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Eyes could serve as early warning of diabetes
A new vision screening device, already shown to give an early warning of eye disease, could give doctors and patients a head start on treating diabetes and its vision complications, a new study shows.

Genes involved in inflammation may hold clue to age-related macular degeneration
A University of Southampton research team, led by Professor Andrew Lotery, has identified a new genetic risk factor for age-related macular degeneration (AMD), a major cause of untreatable blindness in elderly people in developed countries.

Corneal transplant success depends on donor's health
Corneal grafts obtained from donors dying in the hospital or with cancer may be associated with an increased risk of infection for the recipient, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Compstatin - new drug for vision loss, macular degeneration
University of Florida UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. In a first-of-its-kind safety research study, University of Florida researchers have injected an anti-inflammatory compound into the eye of a person with a sight-robbing disease.

15 Ophthalmology articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
0.86